Inter Pharma PCL (BKK:IP)
4.420
+0.040 (0.91%)
Jun 17, 2026, 11:50 AM ICT
Inter Pharma PCL Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,651 | 2,785 | 1,949 | 3,353 | 5,513 | 5,811 | |
Market Cap Growth | 22.35% | 42.86% | -41.86% | -39.19% | -5.13% | 115.34% |
Enterprise Value | 2,967 | 3,128 | 2,346 | 3,486 | 4,944 | 6,009 |
Last Close Price | 4.38 | 4.52 | 3.16 | 5.42 | 8.77 | 11.56 |
PE Ratio | 19.99 | 22.75 | 53.19 | 66.01 | 46.38 | 55.23 |
Forward PE | - | 22.57 | 22.57 | 20.28 | 27.79 | 41.49 |
PS Ratio | 1.18 | 1.26 | 1.02 | 1.86 | 3.59 | 6.31 |
PB Ratio | 1.13 | 1.21 | 0.90 | 1.58 | 2.61 | 7.42 |
P/TBV Ratio | 2.02 | 2.18 | 1.69 | 2.71 | 4.31 | 8.49 |
P/FCF Ratio | 19.94 | 16.64 | - | 224.13 | 47.64 | - |
P/OCF Ratio | 9.56 | 9.04 | 10.96 | 27.61 | 38.53 | - |
EV/Sales Ratio | 1.32 | 1.41 | 1.23 | 1.94 | 3.22 | 6.52 |
EV/EBITDA Ratio | 9.46 | 11.48 | 16.93 | 20.79 | 23.69 | 35.17 |
EV/EBIT Ratio | 14.38 | 16.29 | 31.61 | 31.87 | 28.94 | 41.22 |
EV/FCF Ratio | 22.31 | 18.69 | - | 233.06 | 42.72 | - |
Debt / Equity Ratio | 0.16 | 0.17 | 0.18 | 0.19 | 0.26 | 0.46 |
Debt / EBITDA Ratio | 1.20 | 1.32 | 2.15 | 1.94 | 2.29 | 2.08 |
Debt / FCF Ratio | 2.84 | 2.40 | - | 26.74 | 4.66 | - |
Net Debt / Equity Ratio | 0.03 | 0.05 | 0.10 | -0.01 | -0.11 | 0.23 |
Net Debt / EBITDA Ratio | 0.26 | 0.44 | 1.51 | -0.08 | -1.14 | 1.06 |
Net Debt / FCF Ratio | 0.54 | 0.71 | -3.51 | -0.89 | -2.06 | -0.68 |
Asset Turnover | 0.69 | 0.71 | 0.64 | 0.60 | 0.70 | 0.88 |
Inventory Turnover | 3.45 | 3.70 | 3.44 | 3.28 | 3.45 | 3.39 |
Quick Ratio | 1.18 | 1.16 | 1.20 | 1.75 | 2.35 | 1.39 |
Current Ratio | 1.80 | 1.73 | 1.87 | 2.51 | 3.04 | 1.99 |
Return on Equity (ROE) | 6.52% | 6.11% | 1.71% | 2.78% | 8.78% | 17.40% |
Return on Assets (ROA) | 4.01% | 3.83% | 1.55% | 2.26% | 4.83% | 8.75% |
Return on Invested Capital (ROIC) | 6.75% | 6.38% | 2.30% | 3.98% | 10.42% | 16.49% |
Return on Capital Employed (ROCE) | 7.90% | 7.40% | 3.00% | 4.40% | 6.60% | 14.70% |
Earnings Yield | 5.00% | 4.40% | 1.88% | 1.52% | 2.16% | 1.81% |
FCF Yield | 5.02% | 6.01% | -3.06% | 0.45% | 2.10% | -4.57% |
Dividend Yield | 1.64% | 1.62% | - | 0.40% | 1.26% | - |
Payout Ratio | - | - | 35.38% | 131.92% | - | 4.59% |
Buyback Yield / Dilution | - | - | - | -13.78% | -11.97% | -1.05% |
Total Shareholder Return | 1.64% | 1.62% | - | -13.38% | -10.71% | -1.05% |